Lisa Maher, MD

AHA Guidelines and Patient Mortality

Video content above is prompted by the following:

Please discuss atherosclerotic cardiovascular disease (ASCVD).

Videos

Atherosclerotic cardiovascular disease (ASCVD) is a condition characterized by the buildup of atherosclerotic plaques within arterial walls, leading to narrowed and hardened arteries. This process can result in reduced blood flow and increased risk of cardiovascular events such as heart attacks and strokes. Risk factors include high cholesterol, hypertension, smoking, diabetes, and a sedentary lifestyle. Management involves lifestyle modifications, pharmacotherapy, and sometimes surgical interventions. Early detection and intervention are crucial in preventing the progression of ASCVD and reducing associated morbidity and mortality.

Panelists discuss how effective management of dyslipidemia through adherence to AHA guidelines is crucial for reducing cardiovascular mortality rates and improving patient outcomes.

AHA Guidelines and Patient Mortality 

Prevalence of Cardiovascular Disease

Can you review the current prevalence and effects of cardiovascular disease in the United States?

In your opinion, what is contributing to the “rising tide” of this disease?

Please discuss the importance of dyslipidemia management in preventing and managing atherosclerotic cardiovascular disease (ASCVD).

Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality in the United States, with a significant prevalence affecting millions. Contributing factors to the increasing incidence include lifestyle changes, obesity, diabetes, and hypertension. Dyslipidemia management is crucial in preventing and managing atherosclerotic cardiovascular disease (ASCVD) as it directly influences lipid levels, reducing the risk of plaque formation and subsequent cardiovascular events. Effective management strategies, including lifestyle modifications and pharmacotherapy, are essential in mitigating the impact of CVD and improving patient outcomes.

Panelists discuss how cardiovascular disease remains a leading health concern in the United States, examining its rising prevalence, risk factors such as dyslipidemia, and management strategies aligned with AHA guidelines to reduce patient mortality.

Lisa Maher, MD

Articles